Rapid antidepressant effects associated with ketamine have shifted the landscape for the development of therapeutics to treat major depressive disorder (MDD) from a monoaminergic to glutamatergic model. Treatment with ketamine. an N-methyl-D-aspartate (NMDA) receptor antagonist. may be effective. https://www.thebanyantreers.shop/product-category/napkin/